Search results for "Alzheimer's Disease"


 
Results 31 - 40 of about 60 for "Alzheimer's Disease".
Sort by: Relevance | Newest | Oldest

Sniffing out smell disorders

Awareness and early diagnosis are key to improving outcomes in cases of like anosmia and hyposmia, experts say.
https://immattersacp.org/archives/2019/03/sniffing-out-smell-disorders.htm
1 Mar 2019

Five Choosing Wisely recommendations on ordering genetic tests offered

Duplicate genetic tests and apolipoprotein E genetic testing as a predictive test for Alzheimer's disease are just 2 of the “do nots.”
https://immattersacp.org/weekly/archives/2015/07/21/5.htm
21 Jul 2015

Groups release appropriate use criteria for amyloid PET

The Society of Nuclear Medicine and Molecular Imaging and the Alzheimer's Association recently released appropriate use criteria for amyloid positron emission tomography (PET) in clinical practice.
https://immattersacp.org/weekly/archives/2013/02/05/2.htm
5 Feb 2013

What's in an eponym? Discussing namesake diseases

Where do medical eponyms come from? Consider their origins, the reasons why they've fallen out of favor, and why some still, against the odds, endure.
https://immattersacp.org/archives/2021/03/whats-in-an-eponym-discussing-namesake-diseases.htm
1 Mar 2021

No evidence supports modifying lifestyle to slow Alzheimer's progression

Oseltamivir prophylaxis worked, but drug may pose reinfection risks
https://immattersacp.org/weekly/archives/2010/06/15/5.htm
15 Jun 2010

DTC screening tests a source of concern

With the proliferation of the number and scope of direct-to-consumer tests, ACP is concerned about the unnecessary costs and undue anxiety for patients when results lead to follow-up testing to rule out a medical concern.
https://immattersacp.org/archives/2018/06/dtc-screening-tests-a-source-of-concern.htm
1 Jun 2018

Risks of diclofenac sodium, fosamprenavir calcium detailed

Warnings, label changes, recalls, and approvals.
https://immattersacp.org/archives/2010/02/fda.htm
1 Feb 2010

Two antidepressants ineffective for depression in patients with dementia

Sertraline (Zoloft) or mirtazapine (Remeron) was not better than placebo for depression in Alzheimer's disease, and both drugs were associated with higher rates of nausea and drowsiness, a British study found.
https://immattersacp.org/weekly/archives/2011/07/26/2.htm
26 Jul 2011

Alzheimer's patients prepare, enlighten future physicians

A mentoring program pairs Alzheimer's patients with medical students to heighten students' awareness of the skills and strengths of Alzheimer's patients and familiarize them with related care and communication issues.
https://immattersacp.org/archives/2014/05/alzheimers.htm
1 May 2014

Discussing genetic risk may have little impact on patient behavior

The communication of genetic information may depend on how much it is framed as a risk to health or used to inform recommendations for wellness, study authors noted.
https://immattersacp.org/weekly/archives/2016/03/22/4.htm
22 Mar 2016

Result Page: Prev   1   2   3   4   5   6   Next